Carter Kevin A. 4

What Happened
Kevin A. Carter, a director of Quipt Home Medical Corp. (QIPT), disposed of common shares and derivative securities on March 16, 2026 as part of a court-approved arrangement under which the company was acquired. He sold 201,160 common shares to the purchaser for US$3.65 per share, receiving $734,234 in cash. The filing also shows a disposition of 5,625 derivative units (reported as N/A per-share) related to equity awards/options under the same arrangement. Separately, 76,732 restricted share units (RSUs) held by Mr. Carter were forfeited and terminated immediately prior to the effective time.

Key Details

• Transaction date and filing: March 16, 2026 (Form 4 filed same day).
• Common shares sold: 201,160 @ US$3.65 = $734,234 cash.
• Derivative securities disposed: 5,625 units (per-share cash amount not listed in the filing).
• RSUs forfeited: 76,732 RSUs terminated immediately prior to the effective time (footnote).
• Reason: Dispositions occurred under a business combination/arrangement where each share (except dissenting shareholders) was converted into the right to receive US$3.65 in cash. Options outstanding were cashed out for the excess of $3.65 over exercise price or cancelled if exercise price ≥ $3.65 (per footnotes).
• Shares owned after transaction: not specified in the filing.
• Timeliness: Filing shows transaction and report date the same day (no late filing noted).

Context
These sales were part of a corporate acquisition arrangement that converted shares and certain equity awards into cash consideration. That means this transaction is a takeover-related cash-out rather than a voluntary open-market sale by the director, and reflects deal terms (payment of $3.65/share and cash-out/cancellation of options/RSUs) rather than a trading decision.